Patent Assignment
Reel/Frame 062066/0201
Change of Name
Recorded: 2022-12-05
Pages: 5
Assignor
TARGACEPT, INC.
Executed: 2015-08-20
Assignee
CATALYST BIOSCIENCES, INC.
100 NORTH MAIN STREET, SUITE 1510, WINSTON-SALEM, NORTH CAROLINA, 27101
Covered Property
(1)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Application:
18/061,354 →
Publication:
US 2023/0295126
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 5, 2022
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 062065/0807 →
Assignment of Assignor's Interest
Dec 5, 2022
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINGER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 062066/0148 →
Release of Security Interest
Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →
Corrective Assignment to Correct the Typographical Error in 2ND Inventor's First Name from Balwinger Singh Bhatti to Balwinder Singh Bhatti Previously Recorded on Reel 062066 Frame 0148. Assignor(S) Hereby Confirms the Assignment.
Feb 10, 2023
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 062699/0981 →